Europe Lipid Market Size & Outlook, 2022-2030
Europe lipid market, 2018-2030 (US$M)
Related Markets
Europe lipid market highlights
- The Europe lipid market generated a revenue of USD 1,715.7 million in 2022.
- The market is expected to grow at a CAGR of 5.6% from 2023 to 2030.
- In terms of segment, clinical was the largest revenue generating phase in 2022.
- Clinical is the most lucrative phase segment registering the fastest growth during the forecast period.
- Country-wise, Germany is expected to register the highest CAGR from 2023 to 2030.
Europe data book summary
| Market revenue in 2022 | USD 1,715.7 million |
| Market revenue in 2030 | USD 2,661.2 million |
| Growth rate | 5.6% (CAGR from 2022 to 2030) |
| Largest segment | Clinical |
| Fastest growing segment | Clinical |
| Historical data covered | 2018 - 2021 |
| Base year for estimation | 2022 |
| Forecast period covered | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Clinical, Pre-clinical |
| Key market players worldwide | Danaher Corp, Evonik Industries AG, Merck KGaA, Croda International PLC, Lipoid, Cargill, Basf SE, Archer-Daniels Midland Co, Koninklijke DSM NV, Kerry Group PLC Class A, Nordic Naturals, Fiserv Inc, Omega Protein |
Other key industry trends
- In terms of revenue, Europe region accounted for 18.3% of the global lipid market in 2022.
- Globally, Asia Pacific is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 6,340.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Lipid Market Scope
Lipid Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Europe lipid market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to lipid market will help companies and investors design strategic landscapes.
Clinical was the largest segment with a revenue share of 18.45% in 2022. Horizon Databook has segmented the Europe lipid market based on clinical, pre-clinical covering the revenue growth of each sub-segment from 2018 to 2030.
Europe is one of the prominent regions with a robust pharmaceutical & medical sector. The research-based pharmaceutical industry in Europe plays a critical role in the region’s growth. According to the European Federation of Pharmaceutical Industries and Associations (EFPIA), in 2020, Europe emerged as the second-largest pharmaceutical products seller with 23.9% of the total pharmaceutical sales.
Amid the COVID-19 pandemic, the European region played an important role in the manufacturing of various doses and vaccines to control and cure the spread of the disease. For instance, the BNT162b vaccine was developed to control the spread of the COVID-19 pandemic.
According to the Medicines & Healthcare Products Regulatory Agency (MHRA), the active ingredient used in the vaccine is encapsulated in lipid nanoparticles. Encapsulation in the lipid nanoparticle capsule enables transfection of the mRNA into host cells.
Reasons to subscribe to Europe lipid market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe lipid market databook
-
Our clientele includes a mix of lipid market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe lipid market , including forecasts for subscribers. This continent databook contains high-level insights into Europe lipid market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Europe lipid market size, by country, 2018-2030 (US$M)
Europe Lipid Market Outlook Share, 2022 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
